269 related articles for article (PubMed ID: 8125716)
1. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.
Elder MJ; Kilvington S; Dart JK
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1059-64. PubMed ID: 8125716
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
Hay J; Kirkness CM; Seal DV; Wright P
Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
[TBL] [Abstract][Full Text] [Related]
3. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
[TBL] [Abstract][Full Text] [Related]
4. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
Larkin DF; Kilvington S; Dart JK
Ophthalmology; 1992 Feb; 99(2):185-91. PubMed ID: 1553206
[TBL] [Abstract][Full Text] [Related]
7. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine.
Narasimhan S; Madhavan HN; K LT
Cornea; 2002 Mar; 21(2):203-5. PubMed ID: 11862096
[TBL] [Abstract][Full Text] [Related]
8. Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole.
Talbott M; Cevallos V; Chen MC; Chin SA; Lalitha P; Seitzman GD; Lietman TM; Keenan JD
Cornea; 2019 Oct; 38(10):1309-1313. PubMed ID: 31306283
[TBL] [Abstract][Full Text] [Related]
9. [Amebicide activity of antiseptics and an antibiotic on 2 Acanthamoeba isolated from corneal ulcers].
Debbasch C; Chaumeil C; Quesnot S; Batellier L; Scat Y
J Fr Ophtalmol; 1998 Oct; 21(8):577-82. PubMed ID: 9833223
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].
Walochnik J; Duchêne M; Eibl H; Aspöck H
Wien Klin Wochenschr; 2003; 115 Suppl 3():10-7. PubMed ID: 15508774
[TBL] [Abstract][Full Text] [Related]
11. Protamine as a potential amoebicidal agent for contact lens disinfection.
Vijay AK; Bandara M; Zhu H; Willcox MD
Optom Vis Sci; 2013 Feb; 90(2):119-24. PubMed ID: 23334310
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba.
Lim L; Coster DJ; Badenoch PR
Clin Exp Ophthalmol; 2000 Apr; 28(2):119-24. PubMed ID: 10933775
[TBL] [Abstract][Full Text] [Related]
13. Amoebicidal or amoebostatic influence of disinfectants used in health facilities and laboratories on corneal strains of Acanthamoeba.
Baltaza W; Padzik M; Szaflik JP; Dybicz M; Hendiger E; Chomicz L
Ann Parasitol; 2017; 63(3):167-172. PubMed ID: 29274209
[TBL] [Abstract][Full Text] [Related]
14. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
[TBL] [Abstract][Full Text] [Related]
15. Opportunistic amoebae: challenges in prophylaxis and treatment.
Schuster FL; Visvesvara GS
Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770
[TBL] [Abstract][Full Text] [Related]
16. In vitro amoebicidal activity of propamidine and pentamidine isethionate against Acanthamoeba species and toxicity to corneal tissues.
Alizadeh H; Silvany RE; Meyer DR; Dougherty JM; McCulley JP
Cornea; 1997 Jan; 16(1):94-100. PubMed ID: 8985640
[TBL] [Abstract][Full Text] [Related]
17. The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
Wysenbeek YS; Blank-Porat D; Harizman N; Wygnanski-Jaffe T; Keller N; Avni I
Cornea; 2000 Jul; 19(4):464-7. PubMed ID: 10928758
[TBL] [Abstract][Full Text] [Related]
18. Acanthamoeba keratitis.
Draulans E; Maudgal PC
Bull Soc Belge Ophtalmol; 1992; 243():115-21. PubMed ID: 1302140
[TBL] [Abstract][Full Text] [Related]
19. [Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].
Donoso R; Mura JJ; López M
Rev Med Chil; 2002 Apr; 130(4):396-401. PubMed ID: 12090104
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
